Import safety summit
This article was originally published in The Tan Sheet
Executive Summary
FDA Commissioner Andrew von Eschenbach will moderate a discussion on the legal and regulatory safety and security requirements for the drug industry at the Import Safety Summit July 9 in Washington, the Consumer Healthcare Products Association announces. The summit, cosponsored by CHPA and other trade and advocacy groups, will include a keynote address by Health and Human Services Secretary Michael Leavitt and sessions on import safety challenges, standard-setting, auditing and certification efforts in an evolving global marketplace...
You may also be interested in...
Unprecedented To Lawful: Regulatory Precedent Needed For Cannabinoids’ Use In Supplements?
“This is truly uncharted territory because we’ve never had this situation,” says CHPA regulatory VP David Spangle. Asking Congress instead to instruct FDA to first determine a safe daily limit would be a threatening precedent for the supplement market, says CRN CEO Steve Mister. “That really turns DSHEA on its head.”
Colfax Plans To Split To Form Separate Medtech And Fabtech Companies
The yet-to-be-named medtech company will focus on orthopedic implants and bracing and recovery devices.
What Does A Typical Refuse-To-File Letter Look Like?
Our infographic offers a composite sketch from a decade of US FDA data on refuse-to-file letters.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: